Table 4 Analysis of clinicopathologic factors associated with resolution of LDL-cholesterol at 6 month
From: Changes of lipid profiles after radical gastrectomy in patients with gastric cancer
Abnormal → Abnormal (n = 45) | Abnormal → Normal (n = 48) | OR (95% CI) | pvalue | Adjust OR (95% CI) | pvalue | |
|---|---|---|---|---|---|---|
Sex | ||||||
Male | 21(46.67) | 34(70.83) | 1 | 1 | ||
Female | 24(53.33) | 14(29.17) | 0.36(0.153–0.847) | 0.0192 | 0.39(0.16–0.95) | 0.0369 |
Age (years) | ||||||
Mean(SD) | 58.71(8.56) | 57.85(11.28) | 1 | |||
Median(range) | 61.00(38.00–73.00) | 58.00(36.00–81.00) | 0.99(0.95–1.03) | 0.6786 | ||
Stage | ||||||
IA | 37(82.22) | 23(47.92) | 1 | |||
IB | 2(4.44) | 5(10.42) | 4.02(0.72–22.47) | 0.9480 | ||
IIA | 1(2.22) | 3(6.25) | 4.83(0.47–49.22) | 0.9534 | ||
IIB | 2(4.44) | 6(12.5) | 4.83(0.90–25.97) | 0.9534 | ||
IIIA | 1(2.22) | 3(6.25) | 4.83(0.47–49.22) | 0.9534 | ||
IIIB | 5(10.42) | Inf | 0.9148 | |||
IIIC | 2(4.17) | Inf | 0.9435 | |||
Comorbidity | ||||||
No | 23(51.11) | 19(39.58) | 1 | |||
Yes | 22(48.89) | 29(60.42) | 1.60(0.70–3.63) | 0.2654 | ||
DM | ||||||
No | 42(93.33) | 39(81.25) | 1 | |||
Yes | 3(6.67) | 9(18.75) | 3.23(0.82–12.81) | 0.0952 | ||
HBP | ||||||
No | 35(77.78) | 36(75) | 1 | |||
Yes | 10(22.22) | 12(25) | 1.17(0.45–3.05) | 0.7529 | ||
Op approach | ||||||
Open | 35(77.78) | 40(83.33) | 1 | |||
Laparoscopic | 10(22.22) | 8(16.67) | 0.70(0.25–1.97) | 0.4992 | ||
Resection extent | ||||||
Total | 8(17.78) | 19(39.58) | 1 | 1 | ||
Subtotal | 37(82.22) | 29(60.42) | 0.33(0.13–0.86) | 0.0234 | 0.36(0.14–0.97) | 0.0438 |
Reconstruction | ||||||
B-I | 8(17.78) | 4(8.33) | 1 | 1 | ||
B-II | 29(64.44) | 22(45.83) | 1.52(0.41–5.69) | 0.3491 | 1.38(0.36–5.32) | 0.3663 |
RY | 8(17.78) | 22(45.83) | 5.50 (1.29–23.39) | 0.0050 | 4.47(1.01–19.68) | 0.0143 |